Archive for the Category » Publikacje «

26.11.2012 | Autor:

Conference:
Restorative Reproductive Medicine Update
Research and Practical Applications

On July 11 2012, Salt Lake City, Utah, USA will be the setting for the Restorative Reproductive Medicine Update and a fundraising Banquet. We look forward to meeting many of you there.

Tuesday July 10 from 6.00 PM to 9.00 PM for the Banquet and Wednesday July 11, 2012 from 8.00 AM to 5.00 PM MDT

Our presenters are world-class and will be outlining the challenges with current standard reproductive care and the solutions with Restorative Reproductive Medicine. Make sure you do not miss out on these incredible presentations:

Conference Presentations Include:

26.11.2012 | Autor:

Poniższy wykres przedstawia prawidłowy poziom progesteronu – hormonu odpowiedzialnego m.in. za prawidłowy rozwój dziecka w ciąży i jej utrzymanie ciąży. Wskazane jest przebadanie poziomu tegoż hormonu (badanie krwi). Przed planowaniem poczęcia dziecka poziom progesteronu bada się 7-go dnia po owulacji (po skoku temperatury) i powinien wynosić minimum 16 ng/ml. W czasie ciąży zagrożonej albo po wcześniejszym poronieniu wskazane jest badanie poziomu progesteronu co dwa tygodnie i porównywanie z normami dla danego tygodnia ciąży.  Niski poziom progesteronu jest często przyczyną wielu zaburzeń w ciąży a nawet utraty dziecka tj. poronienia.

Normy progesteronu w ciąży, więcej na: http://www.naprotechnology.pl/progesterone.php

 

 Odpowiedni poziom progesteronu w ciąży: Czytaj dalszą część wpisu »

26.11.2012 | Autor:

Barbara Luke, Sc.D., M.P.H., Morton B. Brown, Ph.D., Ethan Wantman, M.B.A.,
Avi Lederman, B.A., William Gibbons, M.D., Glenn L. Schattman, M.D.,
Rogerio A. Lobo, M.D., Richard E. Leach, M.D., and Judy E. Stern, Ph.D.

BACKGROUND
Live-birth rates after treatment with assisted reproductive technology have traditionally been reported on a per-cycle basis. For women receiving continued treatment,
cumulative success rates are a more important measure.
METHODS
We linked data from cycles of assisted reproductive technology in the Society for
Assisted Reproductive Technology Clinic Outcome Reporting System database for the
period from 2004 through 2009 to individual women in order to estimate cumulative
live-birth rates. Conservative estimates assumed that women who did not return for
treatment would not have a live birth; optimal estimates assumed that these women
would have live-birth rates similar to those for women continuing treatment.
RESULTS
The data were from 246,740 women, with 471,208 cycles and 140,859 live births.
Live-birth rates declined with increasing maternal age and increasing cycle number
with autologous, but not donor, oocytes. By the third cycle, the conservative and
optimal estimates of live-birth rates with autologous oocytes had declined from
63.3% and 74.6%, respectively, for women younger than 31 years of age to 18.6% and
27.8% for those 41 or 42 years of age and to 6.6% and 11.3% for those 43 years of
age or older. When donor oocytes were used, the rates were higher than 60% and
80%, respectively, for all ages. Rates were higher with blastocyst embryos (day of
transfer, 5 or 6) than with cleavage embryos (day of transfer, 2 or 3). At the third
cycle, the conservative and optimal estimates of cumulative live-birth rates were,
respectively, 42.7% and 65.3% for transfer of cleavage embryos and 52.4% and
80.7% for transfer of blastocyst embryos when fresh autologous oocytes were used.
CONCLUSIONS
Our results indicate that live-birth rates approaching natural fecundity can be achieved
by means of assisted reproductive technology when there are favorable patient and
embryo characteristics. Live-birth rates among older women are lower than those
among younger women when autologous oocytes are used but are similar to the
rates among young women when donor oocytes are used. (Funded by the National
Institutes of Health and the Society for Assisted Reproductive Technology.)

 

Czytaj więcej: PDF – IVF Paper by Luke 2012

Kategoria: Publikacje  | Skomentuj
19.11.2012 | Autor:

abp Dziega -Slowo -Metropolity – 18_XI_2012 na 33. niedzielę zwykłą

Kategoria: Materiały, Publikacje  | Skomentuj
12.11.2012 | Autor:

Praca magisterska Pani mgr Katarzyny Ledwig zrealizowana na Wydziale Nauk o Zdrowiu Uniwersytetu Medycznego we Wrocławiu pod kierunkiem Pana prof. dr hab. Mariana Goludy

Diagnostyka i terapia nieplodnosci w NaProTECHNOLOGY-pdf

 

Kategoria: Publikacje  | Skomentuj
08.11.2012 | Autor:

Upcoming Webinar with the International IRRM http://conta.cc/SY6avD

http://www.iirrm.org/

Kategoria: Aktualności, Publikacje  | Skomentuj
05.11.2012 | Autor:


Kategoria: Publikacje  | Tagi: , , ,  | Skomentuj
05.10.2012 | Autor:
Journal Article
An Ethical Comparison between In-Vitro Fertilization and NaProTechnology An Ethical Comparison between In-Vitro Fertilization and NaProTechnology

Journal Linacre Quarterly
Publisher Catholic Medical Association
ISSN 0024-3639 (Print)
Subject TheologyClinical MedicineEthics and Philosophy of Medicine
Issue Volume 79, Number 1 / February 2012
Category Article
Pages 57-72
Online Date Thursday, April 19, 2012
Authors
Juan R. Vélez, M.D., priest1

1 Prelature of Opus Dei

Abstract

In vitro fertilization (IVF) is morally objectionable for a number of reasons: the destruction of human embryos, the danger to women and newborn infants, and the replacement of the marital act in procreation. Recent studies have shown a significant risk of maternal death and morbidity associated with ovarian hyper-stimulation syndrome and multiple pregnancies after IVF. Due to lack of uniform regulations for IVF clinics, there is under-reporting of the adverse effects. NaProTechonology is one ethical alternative to IVF for female infertility. One study has confirmed earlier findings that NaProTechonology results in a number of live births similar to that of assisted reproductive technology, without the danger to women and newborn infants. Adoption of born children is another ethical and praiseworthy alternative to IVF.

Kategoria: Publikacje  | Skomentuj
05.10.2012 | Autor:

 

Kwartalinik FIDES ET RATIO „W TROSCE O RODZINĘ”

 

dr Irena Grochowska

INSTYTUT EKOLOGII I BIOETYKI WFCH, UKSW

INTEGRALNY WYMIAR LUDZKIEJ SEKSUALNOŚCI W MODELU SPICE PROFESORA THOMASA HILGERSA

 

Przyjęcie i wyrażanie kobiecości i męskości są wyrazem seksualności człowieka. Natura  człowieka jest seksualna i wszystko co człowiek czyni zawsze nosi znamię jego płciowości, kobiecości lub męskości (Półtawska, 2002, s. 5).

Dzisiejsza kultura uwypukla znaczenie fizyczności i pożądliwości i bardziej skupia się na erotyzmie człowieka niż na jego wieloaspektowej seksualności. Zainteresowanie skupiające większą  uwagę   na    biologicznym i  fizjologicznym    aspekcie    ludzkiej seksualności prowadzi do oddzielenia miłości od życia i życia od miłości. To sprawia, że mniej  ważna   staje   się  sama  osoba,  a  to  z  kolei  powoduje  psychiczną  i  duchową deprawację.

Antykoncepcja,    sterylizacja,    aborcja,    pornografia   są    konsekwencją    takiego redukcyjnego spojrzenia na ludzką płciowość.

Odpowiedzią na fizyczne i wąskie spojrzenie na ludzką seksualność jest podejście oparte   bardziej   na   rozumieniu   niż   pożądliwości   (to   mózg   jest   centrum   ludzkiej seksualności).

Skupienie  uwagi  na  wszystkich  wymiarach  ludzkiej  seksualności  (duchowy, fizyczny, psychiczny, intelektualny i relacyjny) i dążenie do pełnej integralności w rozwoju człowieka jest osobowe i  wewnętrzne, oznacza łączność pomiędzy miłością a życiem oraz prowadzi do afirmacji człowieka we wszystkich wymiarach.

 

Wprowadzenie

Rozważania  o   ludzkiej  płciowości,  zjednoczeniu  i  wzajemnym  obdarowaniu powinny być  poprzedzone odniesieniem do samego człowieka. Podstawą do rozważań Profesora Hilgersa (2004) na temat seksualności człowieka jest encyklika Humanae Vitae (1968) i przyjęte w niej podejście zgodne z  nauczaniem Kościoła, oparte na filozofii tomistycznej.

Czytaj dalszą część wpisu »

Kategoria: Materiały, Publikacje, Video  | Skomentuj
20.08.2012 | Autor:

Abstract

Objective To study the outcomes of women with infertility or miscarriage treated with natural procreative technology (NaProTechnology or NPT), a systematic medical approach to promoting conception in vivo; and to compare the outcomes with those previously published from a general practice in Ireland.

Design Retrospective cohort study.

Setting An urban Canadian primary care practice in which the physician had a part-time practice in NPT.

Participants Couples with infertility or recurrent miscarriage who received treatment in the practice between August 2000 and July 2006.

Intervention All couples were taught to identify the fertile time of their menstrual cycles using the Creighton Model FertilityCare System (CrMS) and completed a standard NPT evaluation. Many also received additional medical treatment to enhance conception in vivo.

Main outcome measures Live birth was the primary outcome; secondary outcomes included conceptions, multiple births, low birth weight, and prematurity.

Results A total of 108 couples received NPT and were included in the analysis, of which 19 (18%) reported having 2 or more previously unexplained miscarriages. The average female age was 35.4 years. Couples had been attempting to conceive for a mean of 3.2 years. Twenty-two participants (20%) had previously given birth; 24 (22%) had previous intrauterine insemination; and 9 (8%) had previous assisted reproductive technology. The cumulative adjusted proportion of first live births for those completing up to 24 months of NPT treatment was 66 per 100 couples, and the crude proportion was 38%. The cumulative adjusted proportion of first conceptions was 73 per 100 couples, and the crude proportion was 47%. Of the 51 couples who conceived, 12 couples (24%) conceived with CrMS instruction alone, 35 (69%) conceived with CrMS and NPT medical treatment, and 4 (8%) conceived after additional surgical treatment. All births were singleton births; 54% were born at 37 weeks’ gestation or later; and 78% had birth weights of 2500 g or greater.

Conclusion Natural procreative technology in a family physician’s office was effective in treating infertility and miscarriage with outcomes that were comparable to those in an NPT general practice in Ireland. Larger multicentre prospective studies to compare NPT directly to other forms of infertility treatment are warranted.

Copyright© the College of Family Physicians of Canada

 

Pełny tekst

wersja pdf:

Natural Procreative technology for infertility andr ecurrent miscarriage, Outcome in a Canadian family practice_2012

wersja online:

Natural procreative technology for infertility and recurrent miscarriage Outcomes in a Canadian family practice

 

Kategoria: Publikacje  | Skomentuj